ABSTRACT
Acute pulmonary embolism (PE) is a common cause for hospitalization associated with significant mortality and morbidity. Disorders of calcium metabolism are a frequently encountered medical problem. The effect of hypocalcemia is not well defined on the outcomes of patients with PE. We aimed to identify the prognostic value of hypocalcemia in hospitalized PE patients utilizing the 2017 Nationwide Inpatient Sample (NIS). In this retrospective study, we selected patients with a primary diagnosis of Acute PE using ICD 10 codes. They were further stratified based on the presence of hypocalcemia. We primarily aimed to compare in-hospital mortality for PE patients with and without hypocalcemia. In the 2017 NIS, 187,989 patients had a principal diagnosis of acute PE. Among the above study group, 1565(0.8%)had an additional diagnosis of hypocalcemia. 12.4% of PE patients with hypocalcemia died in the hospital in comparison to 2.95% without hypocalcemia. On multivariate regression analysis, PE and hypocalcemia patients had 4 times higher odds (aOR-4.03, 95% CI 2.78-5.84, p<0.001) of in-hospital mortality compared to those with only PE. We observed a similarly high odds of mortality(aOR=4.4) on 1:1 propensity-matched analysis. The incidence of acute kidney injury (aOR=2.62, CI 1.95-3.52, p<0.001), acute respiratory failure (a0R=1.84, CI 1.42-2.38, p<0.001), sepsis (aOR=4.99, CI 3.08-8.11, p<0.001) and arrhythmias (aOR=2.63, CI 1.99-3.48, p<0.001) were also higher for PE patients with hypocalcemia. Thus, PE patients with hypocalcemia have higher in-hospital complications and mortality than those without hypocalcemia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
None
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding sources: None.
Data Availability
None